Gilead Sciences

Regional Sales Director, HCV - Pacific Northwest

United States

Gilead Sciences Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

The ideal candidate should possess a Bachelor’s degree and have at least 7 years of experience in sales, with a strong preference for pharmaceutical sales or a related field. Demonstrated leadership experience is required, along with a deep understanding of pharmaceutical marketing and sales regulations, guidelines, and policies. Strong business acumen and project management skills are also necessary.

Responsibilities

As a Regional Sales Director, the candidate will lead and manage a team of specialists, developing and implementing sales strategies to meet corporate objectives. They will cultivate relationships with key executives and decision-makers, track sales force effectiveness, coordinate with various Gilead functions, and proactively share knowledge of new products and disease state developments. The role involves recruiting, hiring, and managing the sales team, providing coaching and mentoring, serving as a communication liaison, and representing the company at professional events. Additionally, the candidate will analyze industry trends, competitor activities, and utilize exceptional project management skills to lead cross-functional projects with broad organizational impact.

Skills

Leadership
Customer Relationship Management
Strategic Planning
Sales Effectiveness
Inclusion & Diversity
Healthcare Industry Knowledge

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Key Metrics

Foster City, CaliforniaHeadquarters
1987Year Founded
$15,873.6MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Paid family time off and paid parental time off
Generous 401(k) contribution matching
Comprehensive medical plans that cover both physical and mental healthcare
Global Wellbeing Reimbursement
Time Off
Global Volunteer Day
Giving Together Program
Employee Support Programs
Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.
Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.
Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.
Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.
Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.
Investment in digital health technologies enhances Gilead's R&D and patient engagement.
Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI